Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
230
days
H2AC19 promotes lung adenocarcinoma progression via p300/EGR1/MMP-1-mediated angiogenesis
AuthorsFuwen Zuo; Jinlong Yu; Tong Liu; Xiaorui Liu; Jilong Yin; Pengzhong Ding; Yuhan Pang; Zhengdong Luo; Xiaofeng Wang; Ling Guo; Yirong Zhang; Shuang Qi; Lutao Du; Ziying Wang; Fan Yi; Xiaoshi Zhang
AffiliationsDepartment of Clinical Laboratory, National Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital of Shandong University, Jinan 250012, China; Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan 250012, China; Department of Clinical Pharmacology, The Second Hospital of Shandong University, Jinan 250033, China; Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan 250012, China; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, China; School of Chinese Language and Literature, Shandong Normal University, Jinan 250014, China; Shandong Center for Food and Drug Evaruation and Inspection, Jinan 250014, China
344
days
A novel small molecule inhibitor targeting KHSRP methylation suppresses colon cancer progression
AuthorsShuang Chen; Ningjing Zhang; Yuxiao Zhang; Jiebin Fang; Zhen Tang; Dashan Zhang; Xinyi Tang; Yalin Yu; Mengde Xia; Yan Yi; Wanjing Ding; Zhongjun Ma
AffiliationsHainan Institute, Zhejiang University, Sanya 572025, China; Institute of Marine Biology and Pharmacology, Ocean College, Zhejiang University, Zhoushan 316021, China; School of Life Sciences, Westlake University, Hangzhou 310000, China; Center of Synthetic Biology and Integrated Bioengineering, Westlake University, Hangzhou 310000, China
180
days
Targeting SIRT6 epigenetically restrains neutrophil hyperplasia and enhances chemotherapeutic efficacy
AuthorsLuping Wang; Xiaoqian Wu; Panxia Wang; Minshan Zhang; Li Li; Zhenhan Huang; Yang Mao; Haoming Chen; Qin Wen; Wei Liu; Zhibin Huang; Feifei Li; Juan Shen
AffiliationsGuangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China; The Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou 510006, China; School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China; Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, Xinqiao Hospital of Army Medical University, Chongqing 400037, China
162
days
Rhynchophylline rewires DLAT lipoylation via conformational control to reverse mitochondrial bioenergetic collapse against dopaminergic neuronal injury
AuthorsXiaomin Liang; Xunfang Yang; Shuhui Wang; Fangfang Zhuo; Xingzi Hou; Pengfei Tu; Yang Liu; Kewu Zeng; Qingying Zhang
AffiliationsState Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Peking University, Beijing 100191, China
328
days
Cytoplasmic relocation of nuclear Ku70 by Bruceine A augments cGAS–STING pathway-mediated anti-tumor immunity
AuthorsKai Huang; Zhaohui Tang; Qin Gong; Jianing Peng; Yicheng Rong; Tiancong Wu; Weichen Song; Siyu Mao; Yugui Xia; Wenjie Guo; Wen Liu
AffiliationsState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Nanjing Drum Tower Hospital, School of Life Science, Nanjing University, Nanjing 210093, China; Faculty of Life Sciences, University College London, Gower Street, London WC1E6BT, UK; Department of Radiation Oncology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China; Institute of Artificial Intelligence Biomedicine, Nanjing University, Nanjing 210093, China
90
days
Universal off-the-shelf TGF-β1-knockout whole-tumor cell vaccine overcomes immunotherapy resistance in pMMR/MSS tumors
AuthorsWeixiao Yang; Zhexu Dong; Qi Xiong; Yushuang Ren; Lin Zhang; Yi Liu; Jiaqi Han; Tian Tian; Xiaolan Su; Gang Shi; Hongxin Deng
AffiliationsDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China; Geriatrics Research Institute, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China; Department of Radiation Oncology, Yunnan Cancer Hospital & the Third Affiliated Hospital of Kunming Medical University & Peking University Cancer Hospital, Kunming 650118, China
150
days
Neutralizing dentin sialophosphoprotein facilitates tumor vascular normalization in colorectal cancer by blocking the crosstalk between tumor cells and endothelial cells
AuthorsChaoqun Liu; Rui Zhou; Weiwei Liu; Rui Li; Jun Xiao; Jianghua Wu; Ziyan Ning; Zilin Chen; Cheng Qian; Yujie Zhang; Wandie Lin; Liang Zhao
AffiliationsDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
190
days
Novel circUnc79 regulates morphine-induced reward memory via the miR-149-3p/EAAT2 axis and glutamatergic plasticity
AuthorsXixi Yang; Feifei Gao; Zhuojin Yang; Dongyu Yu; Jie Chen; Zhen Yao; Qi Liao; Jingsi Yang; Junlin Liu; Boyuan Gu; Yuxiang Zhang; Chunxia Yan
AffiliationsCollege of Forensic Medicine, Key Laboratory of National Health Commission for Forensic Medicine, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China; Bio-evidence Sciences Academy, Science and Technology Innovation Harbour of Western China, Xi'an Jiaotong University, Xi-xian 712000, China; National Narcotics Laboratory Shaanxi Branch, Xi-xian 712000, China
253
days
IFI30 reprograms glioblastoma-associated macrophage and induces immune evasion by MAFF/PTGS2 pathway
AuthorsSen Zhang; Wenlin Chen; Liwen Ren; Jie Yi; Xiangjin Zheng; Yihui Yang; Hong Yang; Guanhua Du; Wan Li; Yu Wang; Jinhua Wang
AffiliationsThe State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing 100050, China; Beijing Key Laboratory of Innovative Drug Discovery and Polymorphic Druggability Research for Cerebrovascular Diseases, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China; Air Force Medical Center, PLA, Air Force Medical University, Beijing 100142, China; Department of Neurosurgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China; Department of Clinical Laboratory, Peking Union Medical College Hospital, Beijing 100730, China; Department of Pharmacy, Medical Supplies Center, Chinese PLA General Hospital, Beijing 100853, China
244
days
Design, preclinical evaluation, and multicenter phase 1 clinical study of HZ-A-018 for relapsed or refractory central nervous system lymphoma
AuthorsShenglan Li; Jialiang Lu; Zhuang Kang; Haiyan Yang; Wenbin Qian; Xi Chen; Xianggui Yuan; Miao Hu; Qiuqiu Shi; Xinglu Zhou; Feng Chen; Xiaowu Dong; Wenbin Li
AffiliationsCancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou 310022, China; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; HealZen Therapeutics Co., Ltd., Hangzhou 310018, China; ZJUCPS-HealZen Joint Laboratory of Drug Innovation and Transformation, Zhejiang University, Hangzhou 310058, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days